The activation of the PI3K/AKT pathway effectively enhances the expression of GLUT1, facilitating the increased glucose uptake necessary to meet the high metabolic demands of rapidly proliferating tumor cells (C et al., 2018). Here, SLC2A1 is linked to neoplasm.